Brendan Clark

1.1k total citations
22 papers, 727 citations indexed

About

Brendan Clark is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Brendan Clark has authored 22 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Emergency Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Brendan Clark's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Respiratory Support and Mechanisms (6 papers) and Cardiac Arrest and Resuscitation (3 papers). Brendan Clark is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Respiratory Support and Mechanisms (6 papers) and Cardiac Arrest and Resuscitation (3 papers). Brendan Clark collaborates with scholars based in United States, France and United Kingdom. Brendan Clark's co-authors include Marc Moss, Ellen L. Burnham, Madison Macht, André Williams, Alexander B. Benson, Marc Moss, Todd M. Bull, Kim McFann, Tyree H. Kiser and P. Michael Ho and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Respiratory and Critical Care Medicine and Critical Care Medicine.

In The Last Decade

Brendan Clark

19 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brendan Clark United States 10 417 259 243 133 109 22 727
Caroline Patterson United Kingdom 10 542 1.3× 187 0.7× 129 0.5× 42 0.3× 86 0.8× 23 768
Alexander B. Benson United States 11 394 0.9× 354 1.4× 333 1.4× 21 0.2× 249 2.3× 16 827
Ariel Modrykamien United States 16 424 1.0× 155 0.6× 22 0.1× 133 1.0× 199 1.8× 53 819
John W. Kreit United States 11 401 1.0× 75 0.3× 29 0.1× 206 1.5× 226 2.1× 22 876
Philip Haslam United Kingdom 14 402 1.0× 240 0.9× 45 0.2× 60 0.5× 33 0.3× 38 695
Linda L. Maerz United States 15 140 0.3× 219 0.8× 30 0.1× 60 0.5× 158 1.4× 30 578
Fabrizio Racca Italy 20 580 1.4× 134 0.5× 17 0.1× 54 0.4× 224 2.1× 47 962
Hakan Günen Türkiye 18 845 2.0× 101 0.4× 22 0.1× 103 0.8× 78 0.7× 67 1.2k
Colin Schieman Canada 16 378 0.9× 476 1.8× 16 0.1× 91 0.7× 80 0.7× 41 748
Mary Bauman Canada 17 138 0.3× 318 1.2× 33 0.1× 458 3.4× 40 0.4× 47 1.1k

Countries citing papers authored by Brendan Clark

Since Specialization
Citations

This map shows the geographic impact of Brendan Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Clark more than expected).

Fields of papers citing papers by Brendan Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Clark. The network helps show where Brendan Clark may publish in the future.

Co-authorship network of co-authors of Brendan Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Clark. A scholar is included among the top collaborators of Brendan Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Clark. Brendan Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ostrominski, John W., Anindit Chhibber, Effie Kuti, Brendan Clark, & B.M.K. Donato. (2025). Obesity Medication Treatment Perspectives Among People with Overweight or Obesity. Patient Preference and Adherence. Volume 19. 2887–2899.
3.
Ostrominski, John W., Jamie S. Hirsch, Brendan Clark, et al.. (2025). Risk Factor Control in U.S. Adults With Cardiovascular-Kidney-Metabolic Multimorbidity, 1999-2020. Journal of the American College of Cardiology. 86(3). 217–221.
4.
Sethi, Sanjay, Swetha Palli, Lindsay G.S. Bengtson, et al.. (2023). Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy. 29(7). 791–806. 4 indexed citations
5.
Sethi, Sanjay, Brendan Clark, Lindsay G.S. Bengtson, et al.. (2023). Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History. International Journal of COPD. Volume 18. 625–641. 1 indexed citations
6.
Clark, Brendan, et al.. (2023). Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review. Annals of Pharmacotherapy. 58(8). 857–869. 3 indexed citations
7.
Clark, Brendan, et al.. (2022). Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study. International Journal of COPD. Volume 17. 1483–1494. 8 indexed citations
8.
9.
Kiser, Tyree H., Ellen L. Burnham, Brendan Clark, et al.. (2018). Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism*. Critical Care Medicine. 46(10). 1617–1625. 53 indexed citations
10.
Breathett, Khadijah, Larry A. Allen, Stacie L. Daugherty, et al.. (2018). African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure. JACC Heart Failure. 6(5). 413–420. 91 indexed citations
11.
12.
Kiser, Tyree H., et al.. (2016). 50: EVALUATION OF HALF-DOSE VERSUS FULL-DOSE ALTEPLASE FOR TREATMENT OF PULMONARY EMBOLISM. Critical Care Medicine. 44(12). 99–99. 1 indexed citations
13.
14.
Clark, Brendan, Todd M. Bull, Alexander B. Benson, et al.. (2013). Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Critical Care. 17(3). R92–R92. 30 indexed citations
15.
Clark, Brendan, André Williams, Katharine A. Bradley, et al.. (2013). Alcohol Screening Scores and 90-Day Outcomes in Patients With Acute Lung Injury. Critical Care Medicine. 41(6). 1518–1525. 29 indexed citations
16.
Cecere, Laura M., Emily C. Williams, Haili Sun, et al.. (2012). Smoking cessation and the risk of hospitalization for pneumonia. Respiratory Medicine. 106(7). 1055–1062. 11 indexed citations
17.
Macht, Madison, Brendan Clark, Alexander B. Benson, et al.. (2012). Diagnosis and treatment of post-extubation dysphagia: Results from a national survey. Journal of Critical Care. 27(6). 578–586. 71 indexed citations
18.
Macht, Madison, Brendan Clark, Alexander B. Benson, et al.. (2011). Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness. Critical Care. 15(5). R231–R231. 230 indexed citations
19.
Bull, Todd M., Brendan Clark, Kim McFann, & Marc Moss. (2010). Pulmonary Vascular Dysfunction Is Associated with Poor Outcomes in Patients with Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 182(9). 1123–1128. 147 indexed citations
20.
Grahame, Rodney, Brendan Clark, M. Watson, & Charles E. Polkey. (1991). Toward a rational therapeutic strategy for arachnoiditis. A possible role for d-penicillamine.. PubMed. 16(2). 172–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Patterson Breakdown of academic impact, for papers by Alexander B. Benson Breakdown of academic impact, for papers by Ariel Modrykamien Breakdown of academic impact, for papers by John W. Kreit Breakdown of academic impact, for papers by Philip Haslam Breakdown of academic impact, for papers by Linda L. Maerz Breakdown of academic impact, for papers by Fabrizio Racca Breakdown of academic impact, for papers by Hakan Günen Breakdown of academic impact, for papers by Colin Schieman Breakdown of academic impact, for papers by Mary Bauman
Rankless by CCL
2026